Access to the most comprehensive and growing suite of antibody discovery platforms and services available
Partners in biotech and pharma work within the OmniAb ecosystem to develop new antibody-derived therapeutics. Our experienced team will help to guide you through our broad suite of technologies to identify an optimal discovery path based upon your target and desired drug profile. We can provide end-to-end antibody generation and discovery services, or we can develop specialized work flows to leverage your existing technology and discovery capabilities.
Choose from the broadest range of offerings to fit your needs
Get unlimited access to the full suite of OmniAb transgenic animals, with flexibility to choose which approach best fits your science and requirements.
Join a growing network of more than 75 partners
To explore specific OmniAb platform licensing terms, contact us at [email protected].